Treatment options after sorafenib failure in patients with hepatocellular carcinoma
Author:
Publisher
The Korean Association for the Study of the Liver
Subject
Molecular Biology,Hepatology
Link
http://e-cmh.org/upload/pdf/cmh-2017-0108.pdf
Reference49 articles.
1. Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
2. HCC and angiogenesis: possible targets and future directions
3. Angiogenesis Soluble Factors as Hepatocellular Carcinoma Noninvasive Markers for Monitoring Hepatitis C Virus Cirrhotic Patients Awaiting Liver Transplantation
4. Antiangiogenic therapy in oncology: current status and future directions
5. Modes of resistance to anti-angiogenic therapy
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic Effects of Natural Products on Liver Cancer and Their Potential Mechanisms;Nutrients;2024-05-27
2. Exploring the enhanced stability and therapeutic efficacy of Sorafenib-Cyclodextrin inclusion complex;Journal of Molecular Liquids;2024-05
3. Construction of a Novel Diagnostic Model Based on Ferroptosis-Related Genes for Hepatocellular Carcinoma Using Machine and Deep Learning Methods;Journal of Oncology;2023-02-23
4. Potential Therapeutic Strategies to Combat HCC;Current Molecular Pharmacology;2022-12
5. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances;Frontiers in Pharmacology;2022-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3